Maxim Shevtsov

4.1k total citations · 1 hit paper
129 papers, 2.8k citations indexed

About

Maxim Shevtsov is a scholar working on Molecular Biology, Biomedical Engineering and Biomaterials. According to data from OpenAlex, Maxim Shevtsov has authored 129 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Biology, 40 papers in Biomedical Engineering and 26 papers in Biomaterials. Recurrent topics in Maxim Shevtsov's work include Heat shock proteins research (43 papers), Nanoparticle-Based Drug Delivery (22 papers) and Bone Tissue Engineering Materials (14 papers). Maxim Shevtsov is often cited by papers focused on Heat shock proteins research (43 papers), Nanoparticle-Based Drug Delivery (22 papers) and Bone Tissue Engineering Materials (14 papers). Maxim Shevtsov collaborates with scholars based in Russia, Germany and United States. Maxim Shevtsov's co-authors include Gabriele Multhoff, Avinash Sonawane, Rashmirekha Pati, Huile Gao, B. P. Nikolaev, L. Yakovleva, Irina V. Guzhova, А. В. Добродумов, Yaroslav Marchenko and Atsushi Shibata and has published in prestigious journals such as SHILAP Revista de lepidopterología, Biomaterials and Advanced Functional Materials.

In The Last Decade

Maxim Shevtsov

120 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nanoparticle Vaccines Against Infectious Diseases

2018 354 citations Maxim Shevtsov et al. profile →

Peers

Countries citing papers authored by Maxim Shevtsov

Since Specialization

Citations

This map shows the geographic impact of Maxim Shevtsov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maxim Shevtsov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maxim Shevtsov more than expected).

Fields of papers citing papers by Maxim Shevtsov

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maxim Shevtsov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maxim Shevtsov. The network helps show where Maxim Shevtsov may publish in the future.

Co-authorship network of co-authors of Maxim Shevtsov

This figure shows the co-authorship network connecting the top 25 collaborators of Maxim Shevtsov. A scholar is included among the top collaborators of Maxim Shevtsov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maxim Shevtsov. Maxim Shevtsov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	More than Just Protein Folding: The Epichaperome, Mastermind of the Cancer Cell 2025 ·Cells ·(unknown), Maxwell Hubert Antwi, (unknown), Stephanie E. Combs, Maxim Shevtsov	3
2	Plasma Membrane Epichaperome–Lipid Interface: Regulating Dynamics and Trafficking 2025 ·Cells ·(unknown), (unknown), (unknown), (unknown), Zsolt Balogi, Zsolt Török, László Vı́gh, Stephanie E. Combs, Maxim Shevtsov	0
3	Characterization and Therapeutic Assessment of Phytomediated Silver Nanoparticles Produced from the Stem Bark of Bombax ceiba 2025 ·Drug Research ·(unknown), Mahendar Porika, (unknown), Anand Kishore Kola, Tomy Muringayil Joseph, Maxim Shevtsov, Shirish H. Sonawane	0
4	Effect of the solvent on the green synthesis of NIR active polymeric nanoparticles and their in vitro photothermal therapeutic validation 2025 ·Biomedical Materials ·A.P. Srivastava, (unknown), (unknown), Maxim Shevtsov, Sharad Gupta	0
5	Comparison In Vitro Study on the Interface between Skin and Bone Cell Cultures and Microporous Titanium Samples Manufactured with 3D Printing Technology Versus Sintered Samples 2024 ·Nanomaterials ·Maxim Shevtsov, Emil Pitkin, Stephanie E. Combs, (unknown), (unknown), Mark Pitkin	3
6	Targeting PfProhibitin 2-Hu-Hsp70A1A complex as a unique approach towards malaria vaccine development 2024 ·iScience ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maxim Shevtsov, (unknown), Anand Ranganathan, Shailja Singh	4
7	Hybrid-integrated devices for mimicking malignant brain tumors (“tumor-on-a-chip”) for in vitro development of targeted drug delivery and personalized therapy approaches 2024 ·Frontiers in Medicine ·Tatiana M. Zimina, (unknown), Kamil G. Gareev, Natalia Mikhailova, Stephanie E. Combs, Maxim Shevtsov	3
8	Tumor Microenvironment Modulation by Cancer-Derived Extracellular Vesicles 2024 ·Cells ·(unknown), Vadim Kumeiko, (unknown), Huile Gao, Maxim Shevtsov	11
9	Magnetically Controlled Transport of Nanoparticles in Solid Tumor Tissues and Porous Media Using a Tumor-on-a-Chip Format 2024 ·Nanomaterials ·Tatiana M. Zimina, (unknown), (unknown), Viacheslav Fedorov, (unknown), (unknown), Kamil G. Gareev, (unknown), Stephanie E. Combs, Maxim Shevtsov	1
10	A device for studying heterogeneous tumor cell cultures based on a hybrid microfluidic system 2024 ·Biomedical Engineering ·Tatiana M. Zimina, Kamil G. Gareev, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maxim Shevtsov	1
11	Biogenic Nanomagnetic Carriers Derived from Magnetotactic Bacteria: Magnetic Parameters of Magnetosomes Inside Magnetospirillum spp. 2023 ·Applied Sciences ·V. A. Ryzhov, (unknown), Denis S. Grouzdev, Veronika Koziaeva, (unknown), (unknown), Kamil G. Gareev, (unknown), Tatiana M. Zimina, Yaroslav Marchenko, Maxim Shevtsov	3
12	Supramolecular nanomedicines based on host–guest interactions of cyclodextrins 2023 ·SHILAP Revista de lepidopterología ·Fan Tong, Yang Zhou, Yanyan Xu, (unknown), Natalia Yudintceva, Maxim Shevtsov, Huile Gao	42
13	Passing of Nanocarriers across the Histohematic Barriers: Current Approaches for Tumor Theranostics 2023 ·Nanomaterials ·Kamil G. Gareev, (unknown), (unknown), Natalia Yudintceva, Daria A. Goncharova, Stephanie E. Combs, (unknown), (unknown), Maxim Shevtsov	5
14	Application of mesenchymal stem cells and extracellular vesicles in infectious treatment 2022 ·Natalia Yudintceva, Maxim Shevtsov, (unknown), Tatiana Vinogradova, (unknown), (unknown), (unknown)	0
15	Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane 2021 ·Cellular Microbiology ·Lili Zhao, (unknown), (unknown), (unknown), Marc Ringelhan, Karin Wisskirchen, Julia Festag, (unknown), Camille Sureau, Felix Bohne, Michaela Aichler, Volker Bruss, Maxim Shevtsov, (unknown), Frank Momburg, Britta S. Möhl, Ulrike Protzer	6
16	Small-Diameter Vessels Reconstruction Using Cell Tissue-Engineering Graft Based on the Polycaprolactone 2021 ·Cell and Tissue Biology ·Natalia Yudintceva, Yu. A. Nashchekina, Maxim Shevtsov, (unknown), (unknown), (unknown), (unknown)	4
17	Magnetic Properties of Bacterial Magnetosomes Produced by Magnetospirillum caucaseum SO-1 2021 ·Microorganisms ·Kamil G. Gareev, Denis S. Grouzdev, П. В. Харитонский, Demid A. Kirilenko, Andrei Kosterov, Veronika Koziaeva, В. С. Левицкий, Gabriele Multhoff, Elina Nepomnyashchaya, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Maxim Shevtsov	8
18	Hsp70 in Liquid Biopsies—A Tumor-Specific Biomarker for Detection and Response Monitoring in Cancer 2021 ·Cancers ·(unknown), Stefan Stangl, (unknown), (unknown), Maxim Shevtsov, (unknown), Fei Wang, Ali Bashiri Dezfouli, (unknown), C. Ostheimer, Daniel Medenwald, (unknown), Matthias Bache, Martin Schlapschy, Arne Skerra, Gabriele Multhoff	30
19	Preclinical Evaluation of the Hsp70 Peptide Tracer TPP-PEG24-DFO[89Zr] for Tumor-Specific PET/CT Imaging 2018 ·Cancer Research ·Stefan Stangl, Lorenzo Tei, (unknown), Sybille Reder, Jonathan Martinelli, Wolfgang Sievert, Maxim Shevtsov, Rupert Öllinger, Roland Rad, Markus Schwaiger, Calogero D’Alessandria, Gabriele Multhoff	36
20	Phloretin increases the anti-tumor efficacy of intratumorally delivered heat-shock protein 70 kDa (HSP70) in a murine model of melanoma 2015 ·Cancer Immunology Immunotherapy ·(unknown), Olga S. Ostroumova, Elena Y. Komarova, Darya A. Meshalkina, Maxim Shevtsov, Boris A. Margulis, Irina V. Guzhova	28

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact